2025 annual financial data
Celldex Therapeutics 2025 Operating cash flow margin
Direct answer
Operating cash flow margin was -14,063%.
Operating income was -287,400,000 USD and net income was -258,800,000 USD.
Operating cash flow was -210,945,000 USD.
Get free Celldex Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,500,000 USD
- Operating income
- -287,400,000 USD
- Net income
- -258,800,000 USD
- Operating cash flow
- -210,945,000 USD